Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the introduction of five new Vetera® vaccines, including Vetera Gold that offers 7-way protection, and Vetera Gold + VEE, the only equine vaccine with 8-way disease protection in one convenient vaccine. The addition of the five Vetera vaccines in various combinations allows veterinarians the ability to customize vaccination protocols to meet the unique needs of each horse.
Vetera vaccines incorporate the 2005 West Nile virus (WNV) horse isolate that protects against the strain most likely to infect horses today and includes duration of immunity against WNV for at least 12 months in horses as young as four months of age. In addition, the Vetera vaccines include the Ohio/2003, Kentucky/95, and NewMarket/2/93 influenza strains as recommended by the Expert Surveillance Panel on Equine Influenza.
The Vetera Gold portfolio of combination vaccines offers up to 8-way disease protection and various other vaccine combinations through the use of Ultrafil™ Purification Technology.
“The Ultrafil Purification Technology eliminates most of the extraneous proteins and cellular debris so the immune system of the horse can focus on relevant antigens. It’s also a key process when combining up to eight antigens in one vaccine that is administered in a 1 mL dose,” says Dr. John Tuttle, BIVI equine technical services veterinarian.
Proven using aggressive intrathecal and heterologous challenge studies, Vetera Gold + VEE was demonstrated to be 99 percent reaction-free in a multi-state study comprising 1,760 does.1
“While Vetera Gold + VEE offers up to 8-way disease protection with one vaccine, the needs of each horse are different depending on a risk-based analysis,” says Tuttle “Therefore, several additional combination vaccines in the Vetera portfolio have been developed to help meet those individual disease protection needs.”
In addition to Vetera Gold and Vetera Gold+VEE, the vaccine portfolio offers maximum protection against EIV, EHV-1, EHV-4, VEE, EEE, WEE, tetanus and WNV in various combinations. The portfolio also includes:
Vetera® VEWT+EIV/EHV
Vetera® EWT+EIV/EHV
Vetera® EIV+EWT+WNV
Vetera® VEWT+WNV
Vetera® EWT+WNV
Vetera® WNV
For more information on Vetera Gold vaccines, contact Boehringer Ingelheim Vetmedica at 800-325-9167, or visit www.Vetera-Vaccines.com.
Source: Boehringer Ingelheim Vetmedica, Inc.